http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019105639-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_82cbc291d77c061ac9a216f86ec010a3 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15 |
| filingDate | 2018-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2762fc8b5b0c6ef9822b786fc4d02697 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10bd21212dfa0c4edbbfca07029629fc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f045223ce6bca2a32bcbf8ba4e42fea |
| publicationDate | 2019-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2019105639-A |
| titleOfInvention | Diagnostic biomarkers for optic neuropathy |
| abstract | PROBLEM TO BE SOLVED: To provide a biomarker for diagnosis of optic neuropathy, which can accurately determine the onset risk and presence or absence of optic neuropathy, and the severity of optic neuropathy. The risk of developing optic nerve disorder and the presence or absence of onset of optic nerve disorder and the severity of optic nerve disorder are analyzed by analyzing the concentration fluctuation of the present metabolite group (for example, fatty acid, L-acetylcarnitine, monoacyl glyceride) in a biological sample. Determine the degree. 【Selection chart】 None |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114384185-A |
| priorityDate | 2017-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 237.